[go: up one dir, main page]

EP3322397A1 - Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate - Google Patents

Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate

Info

Publication number
EP3322397A1
EP3322397A1 EP16720774.5A EP16720774A EP3322397A1 EP 3322397 A1 EP3322397 A1 EP 3322397A1 EP 16720774 A EP16720774 A EP 16720774A EP 3322397 A1 EP3322397 A1 EP 3322397A1
Authority
EP
European Patent Office
Prior art keywords
antiperspirant
cosmetic agent
aluminum
formula
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16720774.5A
Other languages
German (de)
English (en)
Inventor
Bernhard Banowski
Marcus Claas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP3322397A1 publication Critical patent/EP3322397A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28—Zirconium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Definitions

  • the present invention relates to a method of reducing transpiration of the body and / or reducing body odor caused by transpiration, in which a phosphate-containing antiperspirant cosmetic agent (M1) is applied to the human skin and remains at the site of application for at least 1 hour ,
  • This antiperspirant (M1) contains at most 1% by weight of antiperspirant aluminum and / or aluminum zirconium salts.
  • the use of the at least one phosphate compound in the process according to the invention leads to an antiperspirant effect or to a reduction in body odor caused by perspiration.
  • the present invention relates to the use of at least one phosphate compound for reducing the transpiration of the body and / or for reducing the body odor caused by perspiration.
  • washing, cleansing and caring for one's own body is a basic human need, and modern industry is constantly trying to meet these needs of man in a variety of ways. Especially important for daily hygiene is the permanent elimination or at least reduction of body odor and underarm wetness.
  • Numerous specific deodorant or antiperspirant personal care products are known in the art which have been developed for use in body regions having a high density of sweat glands, especially in the underarm area. These are formulated in a wide variety of dosage forms, for example as powder, in stick form, as aerosol spray, pump spray, liquid and gel roll on application, cream, gel and as impregnated flexible substrates (towels).
  • the cosmetic antiperspirants used to reduce transpiration in prior art processes contain at least one antiperspirant compound, in particular in the form of halides and / or hydroxyhalides of aluminum and / or zirconium.
  • These antiperspirant compounds reduce the sweat secretion of the body by temporarily narrowing and / or obstructing the ducts of the sweat glands, so that the amount of sweat can be reduced by about 20 to 60 percent.
  • they prevent because of their antimicrobial effect the degradation of initially odorless sweat to malodorous compounds and thus the formation of body odor.
  • the halides and / or hydroxy halides of aluminum and / or zirconium contained in the agents used can, in conjunction with the acidic pH of these agents, cause unpleasant skin reactions in some users.
  • the use of the aforementioned antiperspirant compounds can lead to staining on clothing. There is therefore a need to replace the antiperspirant halides and / or hydroxy halides of aluminum and / or zirconium used in methods for reducing perspiration with other antiperspirant cosmetic agents.
  • These ingredients should have a good antiperspirant effect, good skin tolerance and a simple Have formulability.
  • these antiperspirant active ingredients should have no negative impact on the storage stability of the cosmetic products used.
  • the present invention has for its object to provide a method for reducing the transpiration of the body and / or to reduce the induced by the perspiration body odor, which avoids the disadvantages of the prior art or at least attenuates and which contributes to a reliable reduction of underarm wetness good skin compatibility at the same time.
  • the present invention thus relates to a cosmetic method for reducing the transpiration of the body and / or for reducing the body odor caused by transpiration, in which an antiperspirant cosmetic agent (M1) is applied to the human skin and remains at the site of application for at least 1 hour wherein the antiperspirant cosmetic agent (M1) in a cosmetically acceptable vehicle - based on the total weight of the cosmetic agent (M1) - a) at least one phosphate compound, and
  • b) contains at most 1, 0 wt .-% of antiperspirant aluminum and / or aluminum zirconium salts.
  • phosphate-containing cosmetic agents in the method according to the invention results in an excellent reduction of perspiration, in particular axillary sweat, without causing skin irritation. Furthermore, the use of the at least one phosphate compound also a reduced formation of body odor is observed. Thus, the use of extremely small amounts or in the absence of antiperspirant halides and / or hydroxy halides of aluminum and / or zirconium, an effective reduction of armpit sweat and / or body odor is ensured.
  • the cosmetic agents (M1) used according to the invention can be obtained by mixing the at least one phosphate compound with the at least one aluminum and / or aluminum zirconium salt.
  • antiperspirant is understood according to the invention to reduce or reduce the perspiration of the sweat glands of the body.
  • aluminum and / or aluminum zirconium salts in the context of the present invention, in particular chlorides, bromides and iodides of aluminum and / or zirconium and compounds of the formulas AI (OH) y X and Zr (OH) z X, where X in the abovementioned formulas is a halide ion.
  • phosphate compound salts of ortho-phosphoric acid, such as orthophosphates (dihydrogen phosphates), secondary orthophosphates (Hydrogen phosphates) and tertiary orthophosphate understood.
  • the ortho-phosphoric acid contains no organic radicals.
  • this term also includes condensation products of salts of ortho-phosphoric acid, which are formed from hydrogen phosphates by intermolecular dehydration to form POP bridges.
  • the polyphosphates are therefore composed exclusively of phosphorus and oxygen and contain no carbon-containing radicals.
  • the polyphosphates of the present invention can be prepared, for example, by reacting ortho-phosphoric acid and sodium hydroxide or potassium hydroxide, followed by dehydration and melting.
  • phosphate compound is to be understood as meaning mixtures of salts of orthophosphoric acid and of polyphosphates, but the term “phosphate compound” according to the present invention does not include phosphoric acid esters, in particular esters of phosphoric acid with organic radicals.
  • cosmetic oil in the context of the present invention is understood as meaning an oil which is suitable for cosmetic use and which is immiscible with water in all amounts.
  • the cosmetic oil used according to the invention is neither fragrances nor essential oils ,
  • the term "waxes" in the context of the present invention means substances which are kneadable at 20 ° C. or solid to brittle, have a coarse to fine-crystalline structure and are translucent to opaque, but not vitreous, in color Substances above 25 ° C without decomposition, slightly liquid above the melting point (slightly viscous), have a strong temperature-dependent consistency and solubility and are polishable under light pressure.
  • fatty acids as used in the present invention means aliphatic carboxylic acids having unbranched or branched carbon groups of 4 to 40 carbon atoms also be synthetically produced fatty acids.Furthermore, the fatty acids may be monounsaturated or polyunsaturated.
  • fatty alcohols in the context of the present invention means aliphatic, monohydric, primary alcohols which have unbranched or branched hydrocarbon radicals having 4 to 40 carbon atoms ,
  • the term% by weight refers in this case to the total weight of the antiperspirant cosmetic agents (M1) used according to the invention.
  • the antiperspirant cosmetic agent (M1) is advantageously used to reduce transpiration in the armpit and / or to reduce underarm odor. Preferred methods according to the invention are therefore characterized in that the antiperspirant cosmetic agent (M1) is applied to the skin of the armpit.
  • the antiperspirant cosmetic agents (M1) used according to the invention contain the at least one phosphate compound in a cosmetic carrier. According to the invention, this carrier is preferably anhydrous, aqueous, alcoholic or aqueous-alcoholic.
  • An anhydrous carrier is understood according to the invention to mean a carrier which contains less than 10% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of free water.
  • free water is understood to mean water which is different from water of crystallization, water of hydration or similar molecularly bound water of the constituents used.
  • the cosmetic carrier of the antiperspirant cosmetic agent (M1) used in the present invention preferably contains free water in a total amount of less than 8.0% by weight, preferably less than 5.0% by weight, more preferably less than 3.0 % By weight, even more preferably less than 1.0% by weight, in particular 0% by weight, based on the total weight of the antiperspirant cosmetic agent (M1).
  • Anhydrous carriers preferably contain a cosmetic oil which is liquid at 20 ° C. and 1013 hPa and which is selected from the group of (i) volatile cyclic silicone oils, in particular cyclic and linear silicone oils; (ii) volatile non-silicone oils, especially liquid paraffin oils and isoparaffin oils; (iii) nonvolatile silicone oils; (iv) non-volatile non-silicone oils; and (v) their mixtures.
  • a cosmetic oil which is liquid at 20 ° C. and 1013 hPa and which is selected from the group of (i) volatile cyclic silicone oils, in particular cyclic and linear silicone oils; (ii) volatile non-silicone oils, especially liquid paraffin oils and isoparaffin oils; (iii) nonvolatile silicone oils; (iv) non-volatile non-silicone oils; and (v) their mixtures.
  • volatile oil denotes oils which have a vapor pressure of 2.66 Pa to 40,000 Pa (0.02 to 300 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa, preferably 10 to 12,000 Pa (0, 1 to 90 mm Hg), more preferably from 13 to 3000 Pa (0.1 to 23 mm Hg), especially 15 to 500 Pa (0.1 to 4 mm Hg).
  • nonvolatile oils in the context of the present invention means oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1.103 hPa.
  • the carrier used is a nonvolatile silicone oil and / or a nonvolatile non-silicone oil to mask insoluble constituents, such as talc, phosphate compounds or skin-dried ingredients.
  • Particularly preferred according to the invention is the use of mixtures of nonvolatile and volatile cosmetic oils, since in this way parameters such as skin feel, visibility of the residue and stability of the antiperspirant cosmetic agent (M1) used according to the invention are adjusted and the agent is thus better adapted to the needs of the consumer can.
  • the volatile and nonvolatile silicone oils which can be used in the context of the present invention, as well as volatile and nonvolatile non-silicone oils, are disclosed, for example, in the published patent applications DE 10 2010 063 250 A1 and DE 10 2012 222 692 A1.
  • the cosmetic oil which is liquid at 20 ° C. and 1 .013 hPa is preferably used in a total amount of from 1.0 to 98% by weight, preferably from 2.0 to 85% by weight, preferably from 4.0 to 75% by weight.
  • an aqueous carrier contains at least 10% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of free water.
  • the carrier contains free water in a total amount of 15 to 95 wt .-%, preferably from 30 to 70 wt .-%, in particular from 40 to 60 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1).
  • alcoholic carriers contain at least 1.0% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of a C 1 -C 4 -alcohol and / or of a C 2 -C 6 -alkyl alcohol having at least one hydroxyl group.
  • M1 antiperspirant cosmetic agent
  • these include, for example, ethanol, ethylene glycol, isopropanol, 1, 2-propylene glycol, 1, 3-propylene glycol, glycerol, n-butanol, 1, 3-butylene glycol and mixtures thereof.
  • Ethanol is particularly preferably used as the alcoholic carrier.
  • a preferred alcoholic carrier therefore contains ethanol in a total amount of from 1.0 to 99% by weight, preferably from 5.0 to 70% by weight, preferably from 7.0 to 50% by weight, in particular from 10 to 30 Wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1).
  • aqueous-alcoholic carriers are aqueous carriers which additionally contain at least 1.0% by weight, based on the total weight of the antiperspirant cosmetic agent (M1), of a C 1 -C 4 alcohol and / or of a C 2 -C 6 - Alkyl alcohol containing at least one hydroxy group to understand.
  • the antiperspirant and / or odor-inhibiting effect achieved by means of the method according to the invention is preferably achieved exclusively by using at least one phosphate compound. It is therefore within the scope of the present invention advantageous if the cosmetic agent (M1) contains 0 wt .-%, based on the total weight of the cosmetic agent (M1), of antiperspirant aluminum and / or aluminum zirconium salts. Therefore, cosmetic agents (M1) used particularly preferably according to the invention contain no antiperspirant salts of aluminum and / or aluminum zirconium. In particular, none of the following antiperspirant salts of aluminum and / or aluminum zirconium are preferably included:
  • water-soluble astringent inorganic salts of aluminum especially aluminum chlorohydrate, aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum hydroxide, potassium aluminum sulfate, aluminum bromohydrate, aluminum chloride, aluminum sulfate;
  • water-soluble astringent organic salts of aluminum in particular aluminum chlorohydrex-propylene glycol, aluminum chlorohydrex-polyethylene glycol, aluminum-propylene glycol complexes, aluminum sesquichlorohydrex-propylene glycol, aluminum sesqui chlorohydrex-polyethylene glycol, aluminum-propylene glycol-dichlorhydrex, aluminum-polyethylene glycol-dichlorhydrex, aluminum undecylenoyl collagen amino acid, sodium aluminum lactate, sodium aluminum chlorhydroxactate, aluminum lipo amino acids, aluminum lactate,
  • water-soluble astringent inorganic aluminum-zirconium salts in particular aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate;
  • water-soluble astringent organic aluminum-zirconium salts especially aluminum zirconium-propylene glycol complexes, aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine; such as
  • Linear phosphate compounds may be salts of ortho-phosphoric acid as well as linear or chain polyphosphates. The latter are also known under the name catena polyphosphates.
  • Cyclic phosphate compounds which can be used are cyclic polyphosphates, which are also referred to as meta- or cyclo-polyphosphates. Preferred processes according to the invention are therefore characterized in that the at least one phosphate compound is selected from linear or cyclic phosphate compounds and mixtures thereof.
  • linear phosphate compounds of the formula (I) has proved to be particularly advantageous with regard to the antiperspirant and / or odor-inhibiting action.
  • Preferred processes according to the invention are therefore characterized in that the at least one phosphate compound has the formula (I)
  • x and z are integers from 1 to 50, preferably from 1 to 20, preferably from 1 to 10, in particular from 1 to 4,
  • y is an integer from 0 to 100, preferably from 0 to 40, preferably from 0 to 20, in particular from 0 to 4, and
  • M is a mono- or polyvalent cation from the group of alkali metals, alkaline earth metals, transition metals, organic cations or ammonium.
  • organic cations according to the invention cationic compounds are to be understood, which contain at least one carbon atom.
  • the organic cation is selected from the group of basic amino acids, compounds of the formula N + (R) 4, wherein R is linear or branched C 2 -C 10 -alkyl groups, which optionally substituted with at least one hydroxyl group are, imidazolium compounds, pyridinium compounds, pyrrolidinium compounds and sulfonium compounds.
  • Basic amino acids are found in the Side chain on at least one proton acceptor. Such amino acids are, for example, arginine, histidine and lysine.
  • Compounds of the formula N + (R) 4 are understood to mean protonated alkylamines and alkanolamines.
  • alkylamines are monoalkyl, dialkyl and trialkylamines, such as diethyl and triethylamine, diisopropylamine and isopropylamine.
  • Alkanolamines or amino alcohols have both an amino and a hydroxy group.
  • the radical R in the formula N + (R) 4 therefore contains at least one OH group.
  • Alkanolamines which are suitable in the context of the present invention are, for example, choline, which is also known by the name [(2-hydroxyethyl) trimethylammonium and has the formula HO-CH 2 -CH 2 -N + (CH 3) 3.
  • alkanolamines are selected from the group of 2-aminoethan-1-ol (monoethanolamine), 3-aminopropan-1-ol, 4-aminobutan-1-ol, 5-aminopentan-1-ol, 1-aminopropane 2-ol (monoisopropanolamine), 1-aminobutan-2-ol, 1-aminopentan-2-ol, 1-aminopentan-3-ol, 1-amino-pentan-4-ol, 2-amino-2-methyl-propanol , 2-amino-2-methylbutanol, 3-amino-2-methylpropan-1-ol,
  • imidazolium compounds (formula (II I)), pyridinium compounds (formula (IV)), pyrrolidinium compounds (formula (V)) and sulfonium compounds (formula (VI)) preferably have the following formulas (II I) to (VI) in which the radical Ri is in each case hydrogen, OH or a linear or branched C 2 -C 10 -alkyl group which is optionally substituted by at least one hydroxyl group
  • phosphate compound of the formula (I) If linear mono-, di-, tri- and tetra-phosphates are used as the phosphate compound of the formula (I), the use of certain inorganic cations as counterions has proven to be advantageous with regard to the antiperspirant and / or odor-inhibiting effect.
  • Preferred methods of this embodiment of the invention are therefore characterized in that in formula (I) x and z, each independently, are integers from 1 to 4, y is integers from 0 to 4, and M is Na + , K + , Li +, Mg 2+, Ca 2+, Zn 2+ 1/2 Mn 2+ 1/2 Cu 2+, V 3 Fe 3+, 1/4 Zr 4 * 1/4 Ti 4+ or ammonium stands.
  • a cyclic phosphate compound may be alone or in combination with a linear phosphate compound. It is preferred according to the invention, if the at least one phosphate compound has the formula (II) wherein
  • n integers from 2 to 10, preferably from 2 to 8, preferably from 2 to 6, in particular from 2 to 4, and
  • M ' is a mono- or polyvalent cation from the group of alkali metals, alkaline earth metals, transition metals, organic cations or ammonium.
  • organic cation is selected from the group of basic amino acids, compounds of the formula N + (R) 4, wherein R is linear or branched C 2 -C 10 -alkyl groups, which optionally substituted with at least one hydroxyl group are, imidazolium compounds, pyridinium compounds, pyrrolidinium compounds and sulfonium compounds.
  • R is linear or branched C 2 -C 10 -alkyl groups, which optionally substituted with at least one hydroxyl group
  • imidazolium compounds, pyridinium compounds, pyrrolidinium compounds and sulfonium compounds Preferred organic cations have previously been described in connection with the organic cations of the formula (I).
  • n is the integer 3
  • M ' is Na +, K +, Li + 1/2 Mg 2+, 1/2 Ca 2+, 1/2 Zn 2+ 1/2 Mn 2+ 1/2 Cu 2+, V 3 Fe 3+, Zr 4% "% Ti 4+ or ammonium.
  • antiperspirant cosmetic agents which comprise at least one very specific phosphate compound.
  • the cosmetic agent (M1) therefore particularly preferably contains at least one phosphate compound of the formula NaH 2 PÜ 4 and / or the formula ⁇ and / or the formula M '(PO 3) n, in which n is the integer 3 and M' is Na + , K +, Li +, Mg 2+ V, V Ca 2+, 1/2 Zn 2+ 1/2 Mn 2+ 1/2 Cu 2+, V 3 Fe 3+, Zr 4% "1/4 Ti 4 or ammonium.
  • Natnumhydrogenphosphat NaH2PÜ4 of formula and / or sodium pyrophosphate of formula ⁇ - ⁇ and / or metaphosphates in the process of this invention leads to a particularly good reduction of perspiration and / or triggered by the transpiration body odor.
  • the at least one phosphate compound in the cosmetic agent (M1) in specific quantitative ranges.
  • Methods preferred according to the invention are therefore characterized in that the cosmetic agent (M1) contains the at least one phosphate compound in a total amount of from 0.05 to 90% by weight, preferably from 0.1 to 40% by weight, preferably from 1.0 to 25% by weight, in particular from 2.0 to 20% by weight, based on the total weight of the cosmetic agent (M1).
  • a phosphate compound in particular of the formula NahbPC and / or ⁇ and / or of the formula M '(P0 3) n in which n represents the integer 3, and M' is Na +, K +, Li +, 1 / 2Mg 2+ 1/2 Ca 2+, 1/2 Zn 2+, Mn 2+, Cu 2+, Fe 3+ 3,% Zr 4 *% Ti 4+ or ammonium, in the above-mentioned total amounts resulting in the inventive Method for an excellent reduction of transpiration and / or the body odor caused by transpiration. Furthermore, no skin irritation occurs when using the at least one phosphate compound in the aforementioned amounts.
  • the antiperspirant cosmetic agents (M1) used in the process according to the invention preferably have a certain pH. Within this range, a stable formulation of the antiperspirant cosmetic agents (M1) used according to the invention is possible without undesirable interactions between the ingredients occurring. Further, at these pH values, no skin irritation occurs when these agents are used. It is therefore advantageous if the antiperspirant cosmetic agent (M1) has a pH of from pH 2 to pH 10.
  • the desired pH can be adjusted by using acids and bases which are known to the person skilled in the art and are customary in antiperspirant cosmetic agents.
  • the antiperspirant cosmetic agent (M1) used in the method according to the invention may contain, in addition to the ingredients mentioned above, further substances.
  • the antiperspirant cosmetic agent (M1) additionally preferably contains at least one wide adjuvant selected from the group of (i) emulsifiers and / or surfactants; (ii) thickeners; (iii) chelating agents; (iv) deodorant agents; (v) polyethylene glycols; (vi) skin-cooling agents; (vii) pH adjusters; (viii) skin care ingredients, such as moisturizers, skin soothing substances, skin lightening substances, skin smoothing substances; (ix) waxing; (x) preservatives; and (xi) their mixtures.
  • at least one wide adjuvant selected from the group of (i) emulsifiers and / or surfactants; (ii) thickeners; (iii) chelating agents; (iv) deodorant agents; (v) polyethylene glycols; (vi) skin-cooling agents; (vii) pH adjusters; (viii) skin care ingredients, such as moisturizers, skin soothing substances, skin lightening substances,
  • Emulsifiers and surfactants which are preferably suitable according to the invention are selected from anionic, cationic, nonionic, amphoteric, in particular ampholytic and zwitterionic emulsifiers and surfactants.
  • Surfactants are amphiphilic (bifunctional) compounds which consist of at least one hydrophobic and at least one hydrophilic moiety.
  • the hydrophobic residue is preferably a hydrocarbon chain of 8 to 28 carbon atoms, which may be saturated or unsaturated, linear or branched. Most preferably, this C8-C28 alkyl chain is linear.
  • Emulsifiers and surfactants which can preferably be used in the context of the present invention are disclosed, for example, in the published specifications DE 10 2012 222 692 A1, DE 10 2010 063 250 A1 and DE 10 2010 055 816 A1.
  • Substances which are selected from cellulose ethers, xanthan gum, sclerotium gum, succinoglucans, polygalactomannans, pectins, agar, carrageenan (carrageenan), tragacanth, gum arabic, karaya gum, tara gum are preferably used to thicken the antiperspirant cosmetic agents (M1) used according to the invention , Gellan, gelatin, propylene glycol alginate, alginic acids and their salts, polyvinylpyrrolidones, polyvinyl alcohols, polyacrylamides, physically (eg by pre-gelatinization) and / or chemically modified Starches, acrylic acid-acrylate copolymers, acrylic acid-acrylamide copolymers, acrylic acid-vinylpyrrolidone copolymers, acrylic acid-vinylformamide copolymers and polyacrylates.
  • M1 antiperspirant cosmetic agents
  • Cellulose ethers such as carboxymethylcelluloses, are particularly preferably used as thickening agents. Particularly preferred thickeners are furthermore selected from carbomers.
  • Carbomers are thickening crosslinked polymers of acrylic acid, methacrylic acid and their salts. The crosslinking can be effected by means of polyfunctional compounds such as polyalkylene ethers of polysaccharides or polyalcohols, for example sucrose allyl ether, pentaerythritol allyl ether, propylene allyl ether.
  • Preferred in the context of the present invention are homopolymers of acrylic acid or salts thereof which are crosslinked with a pentaerythritol allyl ether, a sucroseallyl ether or a propylene allyl ether.
  • a thickening agent which can be used in the context of the present invention is a copolymer of Cio-30-alkyl acrylate, acrylic acid, methacrylic acid and esters thereof, which is crosslinked with a sucrose allyl ether or a pentaerythritol allyl ether.
  • Thickener based on carbomers are products sold under the trade name Carbopol ® (BF Goodrich, Ohio, USA) available such as Carbopol 934, Carbopol 940, Carbopol 941, Carbopol 971, Carbopol 974, Carbopol EZ2, Carbopol ETD 2001, Carbopol ETD 2020, Carbopol ETD 2050, Carbopol ultrez 10, Carbopol ultrez 20, or Carbopol ultrez 21.
  • Carbopol ® BF Goodrich, Ohio, USA
  • lipophilic thickening agents can be used to thicken the antiperspirant cosmetic agents (M1) used according to the invention.
  • Preferred lipophilic thickeners according to the invention are selected from hydrophobized clay minerals, bentonites, hectorites, pyrogenic silicic acids and derivatives thereof.
  • the antiperspirant cosmetic agents (M1) used according to the invention may comprise at least one chelating agent, in a total amount of from 0.01 to 3.0% by weight, preferably from 0.02 to 1.0% by weight, in particular from 0 , 05 to 0, 1 wt .-%, based on the total weight of the antiperspirant agent (M1) included.
  • preferred chelating agents are selected from the group consisting of ⁇ -alaninediacetic acid, cyclodextrin, diethylenetriaminepentamethylenephosphonic acid, sodium, potassium, calcium disodium, ammonium and triethanolamine salts of ethylenediaminetetraacetic acid (EDTA), etidronic acid, hydroxyethylethylenediaminetetraacetic acid (HEDTA) and their sodium salts, sodium salts of nitrilotriacetic acid (NTA), diethylenetriaminepentaacetic acid, phytic acid, hydroxypropyl cyclodextrin, methylcyclodextrin, Aminotrimethylenphosphonat pentasodium, ethylenediamine pentasodium, diethylenetriamine pentaacetate pentasodium, pentasodium triphosphate, potassium EDTMP, sodium EDTMP, Natriumdihydroxyethylglycina
  • Tetrasodiumiminodisuccinate trisodium ethylenediamine disuccinate, tetra sodium-N, N-bis (carboxymethyl) glutamate, tetrasodium-DL-alanine-N, N-diacetate and desferrioxamine.
  • the deodorizing effect of the antiperspirant cosmetic agents (M1) used according to the invention can be further increased if, in addition, at least one deodorant active ingredient with antibacterial and / or bacteriostatic and / or enzyme inhibiting and / or Odor neutralizing and / or odor absorbing effect in a total amount of 0.0001 to 40 wt .-%, preferably from 0.2 to 20 wt .-%, preferably from 1 to 15 wt .-%, in particular from 1, 5 to 5, 0 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1).
  • ethanol is used in the compositions according to the invention, this does not apply in the context of the present invention as a deodorant active ingredient, but as a constituent of the carrier.
  • Deodorant active substances which are preferred according to the invention are disclosed, for example, in the published patent application DE 10 2010 063 250 A1.
  • Preferred antiperspirant cosmetic agents (M1) used in the present invention may further contain at least one water-soluble polyethylene glycol having 3 to 50 ethylene oxide units.
  • Preferred water-soluble polyethylene glycols are described, for example, in the published patent application DE 10 2010 063 250 A1.
  • the antiperspirant cosmetic agents (M1) used according to the invention may further comprise at least one skin-cooling active agent.
  • Skin-cooling active ingredients suitable according to the invention are, for example, menthol, isopulegol and menthol derivatives, eg.
  • Preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol, menthylpyrrolidonecarboxylic acid and 5-methyl-2- (1-methylethyl) cyclohexyl-N-ethyloxamate, as well as mixtures of these substances, in particular mixtures of menthol and menthyl lactate, menthol, menthol glycolate and menthyl lactate, menthol and menthoxypropanediol or menthol and isopulegol.
  • the pH adjusting agents used are preferably acids and / or alkalizing agents and / or buffers.
  • acids according to the invention preferably inorganic acids (such as hydrochloric acid, sulfuric acid or phosphoric acid) or organic acids (such as citric acid, tartaric acid or malic acid) are used.
  • Alkaliating agents which can be used according to the invention are preferably selected from the group which is formed from ammonia, basic amino acids, alkali metal hydroxides, alkaline earth metal hydroxides, carbonates and bicarbonates, alkanolamines, for example amino-2-methyl-1-propanol, monoethanolamine, triethanolamine, diethanolamine and triisopropanolamine, alkali metal metasilicates , Urea, morpholine, N-methylglucamine, imidazole.
  • the alkali metal ions used are preferably lithium, sodium, potassium, in particular sodium or potassium.
  • Suitable buffer systems in the context of the present invention are, in particular, carbonic bicarbonate buffers, carbonic acid / silicate buffers, acetic acid / acetate buffers, ammonia buffers, citric acid or citrate buffers, buffers based on tris (hydroxymethyl) aminomethane, buffers based on 4- (2-hydroxyethyl) -1-piperazineethanesulfonic acid, buffer based on 4- (2-hydroxyethyl) piperazine-1-propanesulfonic acid, buffer based on 2- (N-morpholino) ethanesulfonic acid and barbital acetate buffer.
  • the choice of the corresponding buffer system depends on the desired pH of the antiperspirant cosmetic agents (M1) used according to the invention.
  • M1 antiperspirant cosmetic agents
  • at least one phosphate compound used according to the invention does not fall under the abovementioned pH adjusting agents in the form of acids and buffer systems.
  • the antiperspirant cosmetic agents (M1) used according to the invention may contain at least one wax.
  • this wax is selected from the group of (i) fatty acid glycerol mono-, di- and triesters; (ii) Butyrospermum Parkii (Shea Butter); (iii) esters of saturated, monohydric Cs -is alcohols with saturated C 12 -is monocarboxylic acids; (iv) linear, primary C 12 C 24 -alkanols; (v) esters of a saturated, monohydric C 16-6 o alkanol and a saturated C 8 C 36 monocarboxylic acid; (vi) glycerol triesters of saturated linear C 12-3o carboxylic acids which may be hydroxylated, such as glycerol esters of hydrogenated vegetable oils; (vii) natural vegetable waxes; (viii) animal waxes; (ix) synthetic waxes; and (x) their mixtures.
  • this wax is selected from the group of (i)
  • the wax is preferably used in a total amount of 0.01 to 60% by weight, preferably 3.0 to 40% by weight, preferably 5.0 to 30% by weight, more preferably 6.0 to 25% by weight. %, based on the total weight of the antiperspirant cosmetic agent (M1).
  • the antiperspirant cosmetic agent (M1) used according to the invention additionally contains at least one preservative.
  • Preservatives which are preferred according to the invention are formaldehyde releasers iodopropynyl-butylcarbamate, parabens, phenoxyethanol, ethanol, benzoic acid and its salts, dibromodicyanobutane, 2-bromo-2-nitro-propane-1,3-diol, imidazolidinylurea, 5-chloro-2-methyl-4- isothiazolin-3-one, 2-chloroacetamide, benzalkonium chloride, benzyl alcohol, salicylic acid and salicylates.
  • preservatives which can be used in the context of the present invention are the substances listed in Annex 6 of the Cosmetics Regulation, as well as cosmetic raw materials with preservative properties or raw materials which support or enhance the preservative action of the abovementioned preservatives.
  • the preservatives are preferably in a total amount of 0.01 to 10 wt .-%, preferably from 0.1 to 7.0 wt .-%, preferably from 0.2 to 5.0 wt .-%, in particular of 0, 3 to 2.0 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1) included.
  • the antiperspirant cosmetic agent (M1) used according to the invention is present as a water-in-oil emulsion.
  • This may in particular be a sprayable water-in-oil emulsion, which can be sprayed by means of a propellant.
  • the antiperspirant cosmetic agents (M1) used according to the invention contain a propellant, this is preferably in a total amount of 1 to 98 wt .-%, preferably from 20 to 90 wt .-%, preferably from 30 to 85 wt .-%, in particular of 40 to 75 wt .-%, based on the total weight of the antiperspirant cosmetic agent (M1) included.
  • Preferred propellants are propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air, oxygen, Nitrous oxide, 1, 1, 1, 3-tetrafluoroethane, heptafluoro-n-propane, perfluoro-ethane, monochlorodifluoromethane, 1, 1-difluoroethane, tetrafluoropropenes, both individually as also in their mixtures. Also hydrophilic propellants, such.
  • hydrophilic gases can be used advantageously in the context of the present invention, when the proportion of hydrophilic gases is selected low and lipophilic propellant gas (eg., Propane / butane) is present in excess.
  • propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants.
  • the antiperspirant cosmetic agent (M1) used according to the invention is present as an oil-in-water emulsion.
  • the cosmetic agent according to the invention is preferably sprayed as a propellant-free pump spray or squeeze spray or applied as a roll-on.
  • the application of the antiperspirant cosmetic agent (M1) used according to the invention can be carried out by various methods.
  • the antiperspirant cosmetic agent (M1) used according to the invention is formulated as a spray application.
  • the spray application is carried out with a spraying device which contains in a container a filling of the liquid, viscous-flowable, suspension-shaped or powdered antiperspirant cosmetic agent (M1) used according to the invention.
  • the filling may be under the pressure of a propellant, as described above (compressed gas cans, compressed gas packages, aerosol dispensers), or it may be a mechanically operated pump sprayer without propellant (pump sprays / squeeze bottle).
  • the atomization of the antiperspirant cosmetic agent (M1) used in the method according to the invention can be effected physically, mechanically or electromechanically, for example by piezoelectric effects or electrical pumps.
  • usable containers and removal devices are described for example in the published patent application DE 10 2012 222 692 A1.
  • the at least one phosphate compound in these sprayable cosmetic compositions (M1) has an average particle size D50 of from 1 to 300 ⁇ m, preferably from 5 to 125 ⁇ m, in particular from 10 to 100 ⁇ m.
  • the antiperspirant cosmetic agent (M1) used according to the invention can furthermore be preferably formulated as a stick, soft solid, cream, gel, roll-on, loose or compact powder.
  • the formulation of the antiperspirant cosmetic agents (M1) used in accordance with the invention in a particular administration form, such as, for example, an antiperspirant roll-on, an antiperspirant stick or an antiperspirant gel, is preferably based on the requirements of the intended use.
  • the antiperspirant cosmetic agents (M1) used according to the invention can therefore be present in solid, semisolid, liquid, disperse, emulsified, suspended, gelatinous, multiphase or powdery form.
  • liquid also includes any types of solid dispersions in liquids.
  • multiphase antiperspirant cosmetic agents (M1) used according to the invention are understood to mean agents which have at least 2 different phases with a phase separation and in which the phases can be arranged horizontally, one above the other, or vertically, ie side by side.
  • the application can, for example, with a Rollkugelapplikator, a Pump atomizer or done by means of a fixed pin.
  • the antiperspirant cosmetic agents (M1) used according to the invention are in the form of solid sticks, it is preferred if the at least one phosphate compound has an average particle size D50 of 1 to 300 ⁇ m, preferably of 5 to 125 ⁇ m, preferably of 10 to 100 ⁇ m. in particular from 3 to 20 ⁇ , has.
  • the antiperspirant cosmetic agent (M1) is contained on and / or in a disposable substrate selected from the group of wipes, pads and bulbs.
  • a disposable substrate selected from the group of wipes, pads and bulbs.
  • wet wipes i. prefabricated for the user, preferably individually packaged, wet wipes, such as. B. from the field of glass cleaning or from the field of wet toilet paper are well known.
  • Such wet wipes which may advantageously also contain preservatives, are impregnated or applied with a sweat-inhibiting cosmetic agent (M1) used according to the invention and preferably individually packaged.
  • Preferred substrate materials are selected from porous sheet-like cloths.
  • wipes include wipes of woven and nonwoven synthetic and natural fibers, felt, paper or foam, such as hydrophilic polyurethane foam.
  • Deodorizing or antiperspirant substrates which are preferred according to the invention can be obtained by impregnation or impregnation or else by melting a sweat-inhibiting cosmetic agent (M1) used according to the invention onto a substrate.
  • Phosphate compound of the formula (I) 2) 0.01-40 0.2-30.1 0-25 2.0-20 and the formula (II) 3) Aluminum and / or aluminum 0 - 1, 0 0 - 0.5 0 - 0.2 0 zirconium salt
  • x and z are each independently integers from 1 to 4
  • y is an integer from 0 to 4
  • M is Na +, K +, Li +, 1 / 2Mg 2+, 1 / 2 Ca 2+, 1/2 Zn 2+ 1/2 Mn 2+ 1/2 Cu 2+, V 3 Fe 3+, 1/4 Zr 4 *% Ti 4+ or ammonium,
  • n represents the integer 3
  • M ' is Na +, K +, Li + 1/2 Mg 2+, 1/2 Ca 2+, 1/2 Zn 2+ 1/2 Mn 2+ 1/2 Cu 2+, Fe 3+ 7 3/4 Zr 4 *, / 4 Ti 4+ or ammonium,
  • Emulsifier selected from the group of ethoxylated C 12 -C 20 -alkanols with 10 to 30 moles of ethylene oxide per mole of alkanol, ethoxylated Cs-C24 carboxylic acids with 10 to 30 moles of ethylene oxide per mole of carboxylic acid, C 8 -C 22 -alkyl mono- and -oligoglycosides , ethoxylated sterols having a degree of ethoxylation of more than 5, partial esters of polyglycerols having 2 to 10 glycerol units and 1 to 4 saturated or unsaturated, linear or branched, optionally hydroxylated Cs-Cso-carboxylic acid residues, in particular ethoxylated C 12 -C 6 -alkanols having 10 to 30 Mol of ethylene oxide per mole of alkanol
  • a further cosmetic agent (M2) which contains at least one antiperspirant active substance.
  • the means (M1) and (M2) can in this case be applied successively or simultaneously in any order become.
  • it may be provided, for example, first to apply the cosmetic agent (M1) and then the cosmetic product (M2).
  • it is also possible first to apply the cosmetic product (M2) and then the cosmetic product (M1).
  • the cosmetic agent (M1) and the cosmetic agent (M2) can be applied simultaneously.
  • the time span between the application of the two means (M1) and (M2) is preferably from 0 seconds (simultaneous application) to 24 hours.
  • a further cosmetic agent (M2) containing in a cosmetically acceptable carrier at least one antiperspirant aluminum and / or aluminum zirconium salt, is applied to the skin.
  • the cosmetic agent (M2) is different from the cosmetic agent (M1).
  • the antiperspirant effect of the method according to the invention can be further improved.
  • a further cosmetic agent (M2) is to be used in the process according to the invention, it is advantageous to store the individual cosmetic agents (M1) and (M2) in separate containers in each case.
  • a further subject of the present invention is therefore a packaging unit (kit-of-parts) comprising - made up separately - a) at least one first container (C1) containing a cosmetic agent (M1) comprising in a cosmetically acceptable carrier at least one phosphate compound and at most 1, 0 wt .-%, based on the total weight of the cosmetic product (M1), antiperspirant aluminum and / or aluminum-zirconium salts, and
  • antiperspirant active ingredient is understood to mean active ingredients which reduce or reduce the perspiration of the sweat glands of the body, but the phosphate compounds contained in the agent (M1) do not fall under these active ingredients.
  • the antiperspirant aluminum and / or aluminum zirconium salts mentioned in connection with the first subject of the invention are preferably used as antiperspirant active ingredient in the cosmetic product (M2).
  • the cosmetic agent (M1) in the container (C1) mutatis mutandis, the statements made with respect to the cosmetic agents (M1) used in the method according to the invention apply.
  • Another object of the present invention is the use of at least one phosphate compound to reduce the transpiration of the body and / or to reduce the body odor caused by perspiration.
  • the amount of perspiration absorbed by the pads was determined gravimetrically, comparing each composition with the corresponding untreated spot on the back. From the gravimetric determination of the amount of sweat, the sweat reduction was determined, with all the values determined were statistically significant.
  • the phosphate compound used in the following examples is preferably sodium pyrophosphate of the formula ⁇ and / or sodium hydrogen phosphate of the formula NaH 2 PO 4
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight) 1 2 3 4 5 6
  • PPG-14 butyl ether 10.0 10.0 10.0 15.3 15.3 15.3 hardened castor oil eg Cutina HR 3.0 3.0 3.0 1, 5 1, 5 1, 5
  • Cyclomethicone (at least 95% by weight cyclopentad ad ad ad siloxane) 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
  • Emulsion (amounts in% by weight)
  • Microemulsions (in% by weight)
  • Antiperspirant cosmetic agents used in the form of roll-ons according to the invention are used in the form of roll-ons according to the invention.
  • Antiperspirant cosmetic agents used according to the invention in the form of a water-in-oil emulsion (amounts in% by weight)
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight)
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight, based on the total weight of the propellant-free composition)
  • Example compositions 27-30 were filled into an aluminum epoxy spray can optionally coated with epoxy-phenolic lacquer in a weight ratio of propellant (butane / propane / isobutane mixture) to suspension of 80:20, 85:15, 60:40 and 90:10, respectively.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight, based on the total weight of the propellant-free composition)
  • Example compositions 31-33 were placed in an optionally epoxy-phenolic varnish-sprayed aluminum spray can at a weight ratio of propellant (butane / propane / isobutane mixture) to W / O emulsion of 80:20, 85:15, 60:40 and 90, respectively : 10 bottled.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents used in the form of O / W emulsions according to the invention are used in the form of O / W emulsions according to the invention.
  • Antiperspirant cosmetic agents used according to the invention (amounts in% by weight, based on the total weight of the propellant-free composition)
  • Example compositions 37-40 were placed in an optionally epoxy-phenolic varnish-sprayed aluminum spray can in a weight ratio of propellant (butane / propane / isobutane mixture) to W / O emulsion of 80:20, 85:15, 60:40 and 90, respectively : 10 bottled.
  • propellant butane / propane / isobutane mixture
  • Antiperspirant cosmetic agents used in the invention in the form of W / O emulsions
  • Antiperspirant cosmetic agents used in accordance with the invention in the form of anhydrous suspension Roll-ons (amounts in% by weight)
  • Aerosil 972 V (hydrophobic) - - 3.0 1, 0
  • Antiperspirant cosmetic agents in the form of PIT used according to the invention are provided.
  • Antiperspirant cosmetic agents used in the form of a microemulsion according to the invention are used in the form of a microemulsion according to the invention.
  • Aerosil 972 SILICA DIMETHYL SILYLATE Evonik
  • Emulgade SE GLYCERYL STEARATE, CETEARETH-20, BASF
  • Plantar ® 2000 DECYL GLUCOSIDE about 50% AS BASF

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne un procédé de réduction de la transpiration et/ou des odeurs corporelles déclenchées par la transpiration, selon lequel des agents cosmétiques anti-perspirants (M1) phosphatés sont appliqués sur la peau humaine et demeurent au moins 1 heure à l'endroit d'application. L'utilisation dudit au moins un composé phosphate dans ce procédé entraîne une action anti-perspirante ou une réduction des odeurs corporelles déclenchées par la transpiration.
EP16720774.5A 2015-07-16 2016-04-26 Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate Withdrawn EP3322397A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102015213344.3A DE102015213344A1 (de) 2015-07-16 2015-07-16 Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von Phosphatverbindungen
PCT/EP2016/059222 WO2017008930A1 (fr) 2015-07-16 2016-04-26 Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate

Publications (1)

Publication Number Publication Date
EP3322397A1 true EP3322397A1 (fr) 2018-05-23

Family

ID=55913605

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16720774.5A Withdrawn EP3322397A1 (fr) 2015-07-16 2016-04-26 Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate

Country Status (4)

Country Link
US (1) US20190008733A1 (fr)
EP (1) EP3322397A1 (fr)
DE (1) DE102015213344A1 (fr)
WO (1) WO2017008930A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107530119B (zh) 2015-02-19 2021-05-07 凯蒂森特生物医药公司 用于产生热量的医疗装置和使用它的治疗方法
DE102018206621A1 (de) * 2018-04-27 2019-10-31 Beiersdorf Ag Antitranspirantwirksame Zubereitung umfassend Erdalkalimetallsalze
JP2023509843A (ja) 2019-12-10 2023-03-10 キャンデサント・バイオメディカル・インコーポレイテッド 熱を発生させるためのメディカル・デバイスおよびそれを用いる処理方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010063250A1 (de) 2010-12-16 2012-06-21 Henkel Ag & Co. Kgaa Wasserhaltige Antitranspirant-Zusammensetzungen mit verbesserter Rückstandsmaskierung
DE102010055816A1 (de) 2010-12-23 2012-06-28 Henkel Ag & Co. Kgaa Deodorant- und Antitranspirant-Zusammensetzungen Zusammensetzungen zur Verhinderung von Körpergeruch
WO2013052454A1 (fr) * 2011-10-04 2013-04-11 Isp Investments Inc. Compositions antisudorales/désodorisantes
DE102012222764A1 (de) * 2012-12-11 2013-10-31 Henkel Ag & Co. Kgaa Kosmetische Mittel enthaltend Phospholipide und ausgewählte Pheromone
DE102012222692A1 (de) 2012-12-11 2013-09-05 Henkel Ag & Co. Kgaa Antibakterielles Kosmetikum
DE102013216381A1 (de) * 2013-08-19 2015-02-19 Henkel Ag & Co. Kgaa juckreizverminderte Antitranspirantien
DE102013225620A1 (de) * 2013-12-11 2015-06-11 Henkel Ag & Co. Kgaa Schweißhemmende kosmetische Mittel ohne aluminiumhaltige Verbindungen II

Also Published As

Publication number Publication date
US20190008733A1 (en) 2019-01-10
DE102015213344A1 (de) 2017-01-19
WO2017008930A1 (fr) 2017-01-19

Similar Documents

Publication Publication Date Title
WO2015085998A1 (fr) Produits cosmétiques antitranspirants sans composés contenant de l'aluminium
WO2015085999A1 (fr) Produit cosmétique anti-transpirant sans composés contenant de l'aluminium
EP3209387A1 (fr) Produits cosmétiques anti-transpirants à teneur en chitosan, exempts d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
EP3057665A1 (fr) Agent cosmétique anti-transpiration contenant des lactates
EP3322397A1 (fr) Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate
EP3621584A1 (fr) Procédés pour réduire la transpiration et/ou les odeurs corporelles en utilisant des composés phosphonates avec des groupes amino et/ou hydroxyle
EP3057564A1 (fr) Produit cosmétique anti-transpirant contenant des acides amidosulfoniques
EP3057568B1 (fr) Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants
EP3057566A1 (fr) Agent cosmétique anti-transpirant contenant des acides polyphosphoriques
EP3057666A1 (fr) Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques
DE102017214252A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs
EP3166693A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de phanères de mammifères, d'oiseaux, de poissons, d'insectes ou de crustacés, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
DE102016209760A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen anionischen Polymeren
EP3322398A1 (fr) Procédé de réduction de la transpiration et/ou des odeurs corporelles à l'aide de composés phosphate et de sels d'aluminium et/ou d'aluminium-zirkonium anti-perspirants
DE102015223846A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Alkoholen
EP3250294B1 (fr) Antitranspirant contenant acide salicylique et des derives acides aminopolycarboxyliques
DE102016218325A1 (de) Verfahren zur Reduzierung des Schweißes und/oder Körpergeruchs unter Verwendung von speziellen Säuren oder deren Derivaten
EP3166694A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de graminées de l'espèce triticum et/ou oryza et/ou avena, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
DE102014221802A1 (de) Verwendung von aluminiumsalzfreien und/oder aluminium-zirconiumsalzfreien kosmetischen Mittel, enthaltend spezielle Aminosäurederivate, zur Reduzierung und/oder Verhinderung von Schweiß
DE102014216896A1 (de) Schweißhemmende kosmetische Mittel mit speziellen Proteinen aus tierischen Sekreten, Sekreten von Insekten oder humanen Sekreten
DE102014216914A1 (de) Schweißhemmende kosmetische Mittel mit speziellen, aus Pilzen isolierten Proteinen
EP3166588A1 (fr) Agents cosmétiques anti-transpirants avec des protéines spéciales provenant de sécrétions animales, de sécrétions d'insectes ou de sécrétions humaines, qui ne contiennent pas d'halogénures et/ou d'hydroxyhalogénures d'aluminium et/ou de zirconium
WO2015085996A1 (fr) Produits cosmétiques antitranspirants contenant du lysozyme et/ou de l'albumine de sérum bovin et/ou de la protéine de yaourt
DE102014216911A1 (de) Schweißhemmende kosmetische Mittel mit speziellen, aus Eiern isolierten Proteinen
DE102014216912A1 (de) Schweißhemmende kosmetische Mittel mit speziellen, aus Fischen oder Vögeln isolierten Proteinen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20171207

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180906